trial · primary record
OBX-115
Tumor Skin
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 254 |
| Primary completion | 2029-06-30 |
| Primary endpoint | Incidence and nature of dose-limiting toxicities (DLTs) |
| Registry ID | NCT06060613 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:47.418Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06060613
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.